Subscribe
Healthcare

FDA greenlights Pfizer vaccine boosters for 16- and 17-year-olds

By Cassidy Morrison
Published
Add Washington Examiner on Google
FDA greenlights Pfizer vaccine boosters for 16- and 17-year-olds

The Food and Drug Administration authorized Pfizer booster shots for 16- and 17-year-olds on Thursday, clearing a hurdle for about 2.6 million more people to get a second dose of the COVID-19 vaccine.

OMICRON FEARS BOOSTING VACCINATIONS

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

COVID-19 FDA Pfizer Pharmaceutical Industry Vaccines